Filter announcements
Loading...
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML’s wholly owned subsidiary Shilpa Therapeutics.
Shilpa Medicare has set September 4, 2026, as the record date for its final dividend for FY 2025-26. This is to identify shareholders eligible for the payout. The dividend, previously proposed by the Board, requires approval at the Annual General Meeting on September 11, 2026. If shareholders approve, the dividend...
Shilpa Medicare's board has proposed a final dividend of Re. 0.60 per equity share (60% of face value) for FY26. This significant payout requires shareholder approval at the forthcoming Annual General Meeting. Once endorsed, the dividend will be disbursed to eligible shareholders as per statutory timelines. This direct return enhances...
Shilpa Medicare has revised its Record Date for the 1:1 Bonus Issue to **October 03, 2025**. Shareholders holding Shilpa Medicare shares on this revised date will be eligible to receive one new bonus equity share for every one share they currently own. This update supersedes the previous announcement, clarifying eligibility...
Shilpa Medicare proposes a 1:1 bonus share issue, pending shareholder approval. Eligibility is set for shareholders on record by September 26, 2025. This move will double the company's paid-up capital from Rs 9.78 Cr to Rs 19.56 Cr. Such issues often enhance liquidity, boost market participation, and reward existing shareholders...
Shilpa Medicare has approved a 1:1 Bonus Issue. This means for every share you hold, you'll receive one additional share. The Record Date for eligibility is set for 26th September 2025. Ensure you hold shares by this date to qualify for the bonus.